Sorry, I don't understand your search. ×
Back to Search Start Over

HIV therapy: more choices, more questions.

Authors :
Allen B
Fischl MA
Mitsuyasu RT
Volberding PA
Source :
Patient Care (Print); 9/15/1993, Vol. 27 Issue 14, p65-76, 6p
Publication Year :
1993

Abstract

Initiating antiretroviral treatment: Zidovudine therapy is recommended for patients with symptomatic HIV infection whose CD4 lymphocyte counts are below 500/microL. Treatment is also an option for asymptomatic patients with counts of 200-500/microL. According to new guidelines, watchful waiting is also an option. The results of the Concorde trial have cast more uncertainty on the long-term usefulness of early antiretroviral therapy in patients with asymptomatic infection. [ABSTRACT FROM AUTHOR]

Details

Language :
English
ISSN :
0031305X
Volume :
27
Issue :
14
Database :
Complementary Index
Journal :
Patient Care (Print)
Publication Type :
Academic Journal
Accession number :
107433620